Skip to main content
Fig. 7 | Journal of Translational Medicine

Fig. 7

From: Gastric cancer vaccines synthesized using a TLR7 agonist and their synergistic antitumor effects with 5-fluorouracil

Fig. 7

Additive effects of 5-FU and T7 − MB on MDSCs using the prophylactic schedule (n ≥ 5 mice/group). a Decreases in MDSCs in splenic lymphocytes were induced by 5-FU and T7 − MB, as determined by flow cytometry. b Flow cytometry results of MDSCs in splenic lymphocytes in the PBS control (left) and 5-FU and T7 − MB combination (right) groups. The data represent the mean ± SE; *P < 0.05 and ***P < 0.001 compared to the PBS control group

Back to article page